Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the page's documentation. It does not modify the study content or any user-facing information on the page.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision badge at the bottom of the page updated from v3.6.0 to v3.6.2, signaling a new build of the page rendering. This update is a minor template/page maintenance change and does not affect study details or user-facing content.SummaryDifference0.1%

- Check30 days agoChange DetectedRecruitment status now shows that no further participants are being sought, indicating the study has finished enrollment. The page also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment labeling.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page's revision label was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor update to the page template or documentation.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Revision label on the page changed from v3.5.3 to v3.5.4, indicating a newer page version of the study listing rather than a change to the study details.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s display/release revision label was updated from v3.5.2 to v3.5.3, indicating a minor tooling or website update rather than a change to the study record information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.